Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06348160 · ClinicalTrials.gov registry record · NA
iHERO Study: Insurance, Health and Economic Resources Online for Emerging Adults With Type 1 Diabetes
A NA study of Type 1 Diabetes, sponsored by University Hospitals Cleveland Medical Center.
- Active
- Registry status
- NA
- Development phase
- 195
- Enrollment target
- 4
- Study locations
NCT06348160 is a NA study of Type 1 Diabetes that is active but no longer recruiting, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 195 participants, below the 823-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (76% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT06348160, a NA study of Type 1 Diabetes, is active but no longer recruiting, sponsored by University Hospitals Cleveland Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 195 participants
- Enrollment target
- 4
- Study locations
Study Summary
This research study aims to test a financial and health insurance iHERO Toolkit for young adults with type1 diabetes. The iHERO Toolkit was developed over one year with the type 1 diabetes community, The Diabetes Link organization, and experts. Now, the investigators want to understand the impact of the iHERO Toolkit on diabetes self-management, financial stress, and health insurance literacy outcomes. The investigators are doing this study because it will help to better understand how to support health insurance and financial stress and improve self-management outcomes in young adults with type 1 diabetes. The investigators want to understand how the iHERO Toolkit helps all young adults with diabetes, but especially those on Medicaid and who are racially or ethnically diverse. The investigators will ask participants to participate at four-time points over one year. For the first time, participants will fill out online enrollment and demographic forms and 9 surveys. The 9 surveys have 8-40 short questions each, estimated to take about 45 minutes. Participants will also be asked to complete a home A1c collection with a University Hospitals team member on Zoom.
Conditions Studied
Interventions
- BEHAVIORAL iHERO Toolkit Resource
Study Locations (4)
California
- Children's Hospital Los Angeles - Los Angeles
Florida
- University of Florida Diabetes Institute - Gainesville
Ohio
- University Hospitals - Cleveland
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2024-05-14 |
| Est. Completion | 2026-11-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06348160
The ClinicalTrials.gov registry entry for NCT06348160 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 195 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 823-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (76% lower). The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which iHERO Toolkit Resource is the first listed.
NCT06348160 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Florida, Ohio.
Frequently Asked Questions
What is clinical trial NCT06348160 about?
NCT06348160 is a clinical study titled "iHERO Study: Insurance, Health and Economic Resources Online for Emerging Adults With Type 1 Diabetes". This research study aims to test a financial and health insurance iHERO Toolkit for young adults with type1 diabetes. The iHERO Toolkit was developed over one year with the type 1 diabetes community, The Diabetes Link organization, and experts. Now, the investigators want to understand the impact of...
What is the current status of trial NCT06348160?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 195 participants. The study started on 2024-05-14. Estimated completion is 2026-11-22.
What conditions does trial NCT06348160 study?
This clinical trial studies the following conditions: Type 1 Diabetes.
What interventions are being tested in trial NCT06348160?
The interventions under investigation include: iHERO Toolkit Resource (BEHAVIORAL).
Who is sponsoring clinical trial NCT06348160?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06348160 being conducted?
This trial has 4 study locations across California, Florida, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
REAL-Fam Feasibility Study for Youth Diabetes Management
RECRUITING · NA
-
AIDANET Pediatrics
RECRUITING · NA
-
A Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 Diabetes
RECRUITING · NA
-
Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 Diabetes Using Automated Insulin Delivery
RECRUITING · NA
-
EMPoWER Study - Strengths-based Behavioral Intervention for Youth With Type 1 Diabetes
RECRUITING · NA
-
Safety and Feasibility of a Machine-Learning Bolus Priming Added to Existing Control Algorithm
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.